Shelby Poland
Family · Bowling Green, KYNPI 1578162046
Payments from drug & device makers
Across 121 payments — averaging $15.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$570
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$164
- Axsome Therapeutics, Inc.$152
- GSK$147
- Novo Nordisk$134
- Pfizer$124
- plus $629 from 16 others
What the payments were for
- Food & beverage$1,920100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $570 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $164 |
| Axsome Therapeutics, Inc. | 5 | $152 |
| GSK | 10 | $147 |
| Novo Nordisk | 8 | $134 |
| Pfizer | 7 | $124 |
| Lilly USA, LLC | 8 | $116 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| Genentech USA, Inc. | 15 | $76 |
| Bayer | 3 | $51 |
| Amgen | 3 | $45 |
| Boehringer Ingelheim | 2 | $37 |
| Dexcom, Inc. | 2 | $33 |
| Novartis | 2 | $31 |
| Evoke Pharma, Inc. | 2 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Shield Therapeutics Inc | 1 | $19 |
| Viatris Specialty LLC | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,920 in reported general payments places this provider in the 75th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 33 | $28,285 |
| UbrelvyUbrogepant | 14 | $14,214 |
| TradjentaLinagliptin | 13 | $6,037 |
| Levothyroxine Sodium | 63 | $1,214 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $1,009 |
| Duloxetine Hcl | 35 | $684 |
| Nabumetone | 14 | $663 |
| Omeprazole | 56 | $631 |
| Atorvastatin Calcium | 111 | $510 |
| Omega-3 Acid Ethyl Esters | 14 | $500 |
| SynthroidLevothyroxine Sodium | 11 | $492 |
| Potassium Chloride | 40 | $424 |
| Ondansetron OdtOndansetron | 21 | $368 |
| Fluticasone Propionate | 31 | $271 |
| Lisinopril | 51 | $263 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $134 | $28,28533 claims |
| AbbVieUbrelvy, Synthroid | $570 | $14,70625 claims |
| Boehringer IngelheimTradjenta | $37 | $6,03713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,374 family providers in Kentucky.
Other family in Bowling Green
- Carrie Parrish NyekanBowling Green$55K
- Cory GearldsBowling Green$51K
- Jeannette DabitBowling Green$28K
- Shellie HardcastleBowling Green$15K
- Ashley ToweBowling Green$14K
- Ayme RowlandBowling Green$14K
- Jenna PoteetBowling Green$14K
- Jacqueline ErbseBowling Green$14K
- Krista NealBowling Green$12K
- Bonnie HillLouisa$372K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.